EA200300527A1 - Новые способы лечения синдрома "усталых ног" - Google Patents
Новые способы лечения синдрома "усталых ног"Info
- Publication number
- EA200300527A1 EA200300527A1 EA200300527A EA200300527A EA200300527A1 EA 200300527 A1 EA200300527 A1 EA 200300527A1 EA 200300527 A EA200300527 A EA 200300527A EA 200300527 A EA200300527 A EA 200300527A EA 200300527 A1 EA200300527 A1 EA 200300527A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment methods
- new treatment
- foot syndrome
- tired
- tired foot
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Fats And Perfumes (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Данное изобретение предусматривает способы лечения и применение гетероциклических аминов и соединений фенилазациклоалкана, а также их фармакологически приемлемых солей для лечения синдрома «усталых ног» (RLS).Отчет о международном поиске был опубликован 2002.09.19.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24466600P | 2000-10-31 | 2000-10-31 | |
PCT/US2001/027785 WO2002036123A2 (en) | 2000-10-31 | 2001-10-29 | New treatments for restless legs syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200300527A1 true EA200300527A1 (ru) | 2003-08-28 |
Family
ID=22923642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200300527A EA200300527A1 (ru) | 2000-10-31 | 2001-10-29 | Новые способы лечения синдрома "усталых ног" |
Country Status (18)
Country | Link |
---|---|
US (2) | US6602868B2 (ru) |
EP (1) | EP1330248A2 (ru) |
JP (1) | JP2004512367A (ru) |
KR (1) | KR20030042037A (ru) |
CN (1) | CN1606442A (ru) |
AR (1) | AR031152A1 (ru) |
AU (1) | AU2002211226A1 (ru) |
BR (1) | BR0115071A (ru) |
CA (1) | CA2421705A1 (ru) |
EA (1) | EA200300527A1 (ru) |
IL (1) | IL155591A0 (ru) |
MX (1) | MXPA03003912A (ru) |
NO (1) | NO20031923L (ru) |
NZ (1) | NZ525574A (ru) |
PE (1) | PE20020514A1 (ru) |
PL (1) | PL360904A1 (ru) |
WO (1) | WO2002036123A2 (ru) |
ZA (1) | ZA200301865B (ru) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6375957B1 (en) | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
ATE323491T1 (de) | 1997-12-22 | 2006-05-15 | Euro Celtique Sa | Peroral zu verabreichende arzneiform enthaltend eine kombination von einem opioid agonisten und naltrexon |
USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
DE10053397A1 (de) * | 2000-10-20 | 2002-05-02 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
DE10066158B4 (de) * | 2000-08-24 | 2007-08-09 | Neurobiotec Gmbh | Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms |
DE10064453A1 (de) * | 2000-12-16 | 2002-07-04 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
ATE493130T1 (de) | 2001-05-11 | 2011-01-15 | Endo Pharmaceuticals Inc | Opioid enthaltende arzneiform gegen missbrauch |
ES2627298T3 (es) * | 2002-04-05 | 2017-07-27 | Mundipharma Pharmaceuticals S.L. | Preparación farmacéutica que contiene oxicodona y naloxona |
US20050079217A1 (en) * | 2002-07-25 | 2005-04-14 | Ganorkar Loksidh D. | Sustained-release tablet composition comprising a dopamine receptor agonist |
WO2004032853A2 (en) * | 2002-10-04 | 2004-04-22 | Pharmacia Corporation | Compositions and methods for treating sexual dysfunction |
MXPA05004297A (es) * | 2002-10-25 | 2005-08-03 | Pharmacia & Upjohn Co Llc | Uso de compuestos heterociclicos tipo amina como agentes neuroprotectores. |
KR101157436B1 (ko) | 2003-09-17 | 2012-07-05 | 제노포트 인코포레이티드 | Gaba 유사체의 전구약물을 이용한 하지불안 증후군의치료 또는 예방 |
EP1604666A1 (en) | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD) |
EP1604667A1 (en) * | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioids for the treatment of the restless leg syndrome |
AP2274A (en) * | 2005-01-28 | 2011-08-19 | Euro Celtiques Sa | Alcohol resistant dosage forms. |
EP1702558A1 (en) | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Method and device for the assessment of bowel function |
EP1695700A1 (en) * | 2005-02-28 | 2006-08-30 | Euro-Celtique S.A. | Dosage form containing oxycodone and naloxone |
JP2009501184A (ja) | 2005-07-13 | 2009-01-15 | エフ.ホフマン−ラ ロシュ アーゲー | 5−ht6、5−ht24としてのベンゾイミダゾール誘導体 |
US20100168119A1 (en) | 2008-11-05 | 2010-07-01 | Pharmorx, Inc. | Compositions and methods for minimizing or reducing agonist-induced desensitization |
KR20110133602A (ko) | 2009-03-10 | 2011-12-13 | 유로-셀티큐 에스.에이. | 옥시코돈 및 날록손을 포함하는 즉시 방출 제약 조성물 |
US8690933B2 (en) * | 2009-08-31 | 2014-04-08 | Brigham Young University | System and method for treating symptoms of restless legs syndrome |
DK2618826T3 (en) * | 2010-09-20 | 2016-08-01 | A Carlsson Res Ab | Phenylpiperdine FOR TREATMENT OF DEMENTIA |
JP6406713B2 (ja) | 2013-01-30 | 2018-10-17 | ファーモレックス セラピューティクス, インコーポレイテッド | 低用量薬剤によるうつ病および他の疾患の処置 |
JP2016525138A (ja) | 2013-07-23 | 2016-08-22 | ユーロ−セルティーク エス.エイ. | 疼痛および腸内ディスバイオシスをもたらす疾患および/または腸内細菌移行に対するリスクを高める疾患に罹患している患者における痛みの治療への使用のためのオキシコドンおよびナロキソンの組み合わせ |
US10821106B2 (en) | 2015-08-21 | 2020-11-03 | Srx Cardio, Llc | Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity |
EP3337788A4 (en) | 2015-08-21 | 2019-03-27 | Portola Pharmaceuticals, Inc. | PHENYLPIPERAZINE PROPROTEIN CONVERTASE SUBTILISIN / -KEXIN TYPE 9 P (CSK9) MODULATORS AND THEIR USE |
EP3337564A4 (en) | 2015-08-21 | 2019-01-23 | Portola Pharmaceuticals, Inc. | COMPOSITION AND METHOD FOR THE USE OF TETRAHYDROISOCHINOLINE SMALL MOLECULES FOR THE BINDING AND MODULATION OF PCSK9 PROTEIN ACTIVITY |
US20190119236A1 (en) | 2016-02-23 | 2019-04-25 | Portola Pharmaceuticals, Inc. | Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9) |
CN110603073B (zh) | 2017-01-05 | 2023-07-04 | 诺克特丽克丝健康公司 | 不宁腿综合征或过度活跃神经治疗 |
WO2021067751A1 (en) | 2019-10-03 | 2021-04-08 | Noctrix Health, Inc. | Peripheral nerve stimulation for restless legs syndrome |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5273975A (en) | 1989-06-09 | 1993-12-28 | The Upjohn Company | Heterocyclic amines having central nervous system activity |
AU653837B2 (en) | 1991-04-17 | 1994-10-13 | Pharmacia & Upjohn Company | Substituted phenylazacycloalkanes as CNS agents |
AUPO274596A0 (en) * | 1996-10-04 | 1996-10-31 | Armstrong, Stuart Maxwell | Method for the treatment of neurological or neuropsychiatric disorders |
US6001861A (en) | 1998-01-16 | 1999-12-14 | Pharmacia & Upjohn Company | Use of pramipexole in the treatment of restless legs syndrome |
US6197339B1 (en) * | 1997-09-30 | 2001-03-06 | Pharmacia & Upjohn Company | Sustained release tablet formulation to treat Parkinson's disease |
SK13312000A3 (sk) | 1998-03-27 | 2001-05-10 | Pharmacia And Upjohn Company | Použitie kabergolínu pri liečbe syndrómu nepokojných nôh |
SE9802546D0 (sv) * | 1998-07-15 | 1998-07-15 | Ross Nicholas Waters | Medicinal product and method for treatment and prevention of dyskinesia |
US6455564B1 (en) | 1999-01-06 | 2002-09-24 | Pharmacia & Upjohn Company | Method of treating sexual disturbances |
DE19938823A1 (de) | 1999-08-19 | 2001-02-22 | Boehringer Ingelheim Pharma | Medikamentöse Behandlung des Restless Leg Syndroms |
ES2253370T3 (es) * | 2000-04-21 | 2006-06-01 | PHARMACIA & UPJOHN COMPANY LLC | Cabergolina para el tratamiento del sindrome de fibromialgia y de fatiga cronica. |
AR033520A1 (es) * | 2000-04-27 | 2003-12-26 | Upjohn Co | (5r)-(metilamino) -5,6-dihidro-4h-imidazo[4,5,1-ij] quinolin-2(1h)-tiona |
-
2001
- 2001-10-23 AR ARP010104960A patent/AR031152A1/es unknown
- 2001-10-24 PE PE2001001052A patent/PE20020514A1/es not_active Application Discontinuation
- 2001-10-29 BR BR0115071-5A patent/BR0115071A/pt not_active IP Right Cessation
- 2001-10-29 CA CA002421705A patent/CA2421705A1/en not_active Abandoned
- 2001-10-29 JP JP2002538934A patent/JP2004512367A/ja not_active Withdrawn
- 2001-10-29 CN CNA018156134A patent/CN1606442A/zh active Pending
- 2001-10-29 MX MXPA03003912A patent/MXPA03003912A/es not_active Application Discontinuation
- 2001-10-29 NZ NZ52557401A patent/NZ525574A/xx unknown
- 2001-10-29 IL IL15559101A patent/IL155591A0/xx unknown
- 2001-10-29 EA EA200300527A patent/EA200300527A1/ru unknown
- 2001-10-29 PL PL36090401A patent/PL360904A1/xx not_active Application Discontinuation
- 2001-10-29 US US10/039,446 patent/US6602868B2/en not_active Expired - Fee Related
- 2001-10-29 AU AU2002211226A patent/AU2002211226A1/en not_active Abandoned
- 2001-10-29 WO PCT/US2001/027785 patent/WO2002036123A2/en not_active Application Discontinuation
- 2001-10-29 EP EP01979241A patent/EP1330248A2/en not_active Withdrawn
- 2001-10-29 KR KR10-2003-7005874A patent/KR20030042037A/ko not_active Application Discontinuation
-
2003
- 2003-03-06 ZA ZA200301865A patent/ZA200301865B/en unknown
- 2003-04-25 US US10/423,078 patent/US6716854B2/en not_active Expired - Fee Related
- 2003-04-29 NO NO20031923A patent/NO20031923L/no unknown
Also Published As
Publication number | Publication date |
---|---|
KR20030042037A (ko) | 2003-05-27 |
US20030212065A1 (en) | 2003-11-13 |
US6602868B2 (en) | 2003-08-05 |
MXPA03003912A (es) | 2004-09-10 |
CA2421705A1 (en) | 2002-05-10 |
NZ525574A (en) | 2004-12-24 |
AU2002211226A1 (en) | 2002-05-15 |
BR0115071A (pt) | 2003-07-29 |
PL360904A1 (en) | 2004-09-20 |
EP1330248A2 (en) | 2003-07-30 |
CN1606442A (zh) | 2005-04-13 |
PE20020514A1 (es) | 2002-06-12 |
WO2002036123A2 (en) | 2002-05-10 |
IL155591A0 (en) | 2003-11-23 |
JP2004512367A (ja) | 2004-04-22 |
ZA200301865B (en) | 2004-06-25 |
AR031152A1 (es) | 2003-09-10 |
NO20031923D0 (no) | 2003-04-29 |
NO20031923L (no) | 2003-06-27 |
US6716854B2 (en) | 2004-04-06 |
US20020107257A1 (en) | 2002-08-08 |
WO2002036123A3 (en) | 2002-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200300527A1 (ru) | Новые способы лечения синдрома "усталых ног" | |
EA200300717A1 (ru) | Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов | |
EA200100971A1 (ru) | Новые соединения и композиции в качестве ингибиторов протеазы | |
EA200200208A1 (ru) | Синергитическая композиция | |
EA200300248A1 (ru) | Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции | |
EA200301215A1 (ru) | Лиганды рецепторов 5-ht и их применение | |
DE60210944D1 (de) | N-substituierte heterocyclische nichtaryl-nmda/nr2b-antagonisten | |
EA200300674A1 (ru) | Получение гетероциклических сульфонамидных ингибиторов бета-амилоида | |
EA200201214A1 (ru) | Замещенные тиоацетамиды | |
EA200300528A1 (ru) | 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6 | |
SV2003000633A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
BG66085B1 (bg) | Фенилаланинови производни | |
EA200500520A1 (ru) | Пуриновые соединения и их применение в качестве лигандов каннабиноидных рецепторов | |
ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
EA200201179A1 (ru) | Производные 2-аминокарбонил-9h-пурина | |
EA200301142A1 (ru) | Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6 | |
DE60121461D1 (de) | Kondensierte pyridoindolderivate | |
EA200300716A1 (ru) | Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6 | |
DE60112306D1 (de) | Kondensierte pyrazindionderivate als pde5 inhibitore | |
DK1458393T3 (da) | Substituerede diketopiperaziner som oxytocinantagonister | |
EA200301143A1 (ru) | Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6 | |
EA200301203A1 (ru) | Новые соединения и композиции как ингибиторы катепсина | |
DE60112960D1 (de) | Kondensierte pyridoindolderivate | |
ATE333457T1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
AP2001002188A0 (en) | 5HT1 antagonists for antidepressant therapy. |